Cutler Group LP Pacira Bio Sciences, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	BUY	$51.49 - $81.64 $25,745 - $40,820	500 Added 50.0%	1,500 $20,000
Q1 2019 May 10, 2019	SELL	$36.47 - $42.17 $91,175 - $105,425	-2,500 Reduced 71.43%	1,000 $5,000
Q3 2018 Nov 07, 2018	BUY	$32.85 - $52.0 $114,975 - $182,000	3,500 New	3,500 $2,000
Q2 2018 Aug 10, 2018	SELL	$27.5 - $39.8 $1.32 Million - $1.91 Million	-48,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$29.98 - $46.35 $1.27 Million - $1.96 Million	42,200 Added 727.59%	48,000 $100,000
Q4 2017 Jan 17, 2018	BUY	$31.85 - $46.95 $159,250 - $234,750	5,000 Added 625.0%	5,800 $26,000
Q3 2017 Oct 17, 2017	BUY	$35.7 - $39.5 $28,560 - $31,600	800	800 $5,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.